Norway, which has suspended the use of AstraZeneca's Covid vaccine until further notice, will send 216,000 doses to Sweden and Iceland at their request, the Norwegian health ministry said Thursday.
The European Medicines Agency has come to the conclusion that the unusual blood clots suffered by numerous people around Europe should be considered as rare side effects of AstraZeneca's Covid-19 vaccine, but that overall the benefits of the jab outweigh the risk.
As Sweden's public health agency warned of a continued "significant rise" in Covid-19 cases, it said it did not believe travel during the winter sports break was a driver of the rising infection rate.
The European Medicines Agency (EMA) concluded on Thursday that the AstraZeneca vaccine was a "safe and effective" tool in the battle against Covid-19 but its investigation could not rule out whether the jab had caused rare cases of blood clotting.
The EU's medicines regulator said Tuesday it was "firmly convinced" the benefits of AstraZeneca's vaccine outweigh potential risks, insisting there was no evidence linking it to blood clots after several nations suspended the shot over health fears. It came as Brussels sealed a deal for 10 million more Pfizer doses.
AstraZeneca in Södertälje was evacuated on Wednesday after dangerous chemicals were at risk of leaking as a result of a power outage affecting southern Stockholm.
Anglo-Swedish pharmaceutical giant AstraZeneca has started preliminary preparations for the possibility of a hard Brexit, which would mean moving some of its operations away from the UK, the company's chairman revealed to a Swedish newspaper.
After fighting off a fierce takeover bid from Pfizer, Swedish-British drugmaker AstraZeneca raised its 2014 earnings outlook and posted rising second quarter sales on Thursday.
Sweden's prime minister has said that a Pfizer takeover of AstraZeneca could slash jobs, undermine research, and offer little value for money for Swedish citizens whose taxes have been invested in the life sciences.
Sweden's finance minister has recalled that Pfizer's old promise to keep Pharmacia in Sweden fell flat, which makes him worried as the US drugs giant moves in on Anglo-Swedish pharmaceuticals company AstraZeneca.
US drugs giant Pfizer has said it was disappointed with Anglo-Swedish pharmaceuticals company AstraZeneca for not only rejecting its takeover bid, but refusing to discuss alternatives.
Losing Astra-Zeneca to Pfizer appears inevitable, because Sweden has a bad track record of withstanding short-sighted investors, warns industry expert Torun Nilsson.
As Anglo-Swedish drug giant AstraZeneca rejected Pfizer's renewed bid on Friday, Sweden's enterprise minister said she feared any future take-over could result in a loss of jobs in Sweden.
Anglo-Swedish pharmaceuticals giant AstraZeneca announced on Thursday it would buy Bristol-Myers Squibb's stake in their diabetes venture at a price tag of over $4 billion.
AstraZeneca said on Tuesday that it has agreed to buy US-based cancer drugs company Amplimmune, as the Anglo-Swedish pharmaceuticals group seeks to bolster its flagging pipeline of new products.
Anglo-Swedish pharmaceuticals giant AstraZeneca announced a 4-percent revenue decrease in the second quarter, citing the loss of exclusivity of several key brands.
Sweden's once flourishing pharmaceutical testing industry has been decimated in recent years, suffering an 85-percent drop according to new figures that industry experts describe as "deeply troubling".
Anglo-Swedish pharmaceutical company AstraZeneca on Thursday said that its net profit tumbled 38 percent in the first quarter of the year to $1.0 billion after losing market exclusivity for some of its key drugs.
A year after Anglo-Swedish pharmaceuticals giant AstraZeneca announced the closure of its research facilities in Södertälje, south of Stockholm, officials are cheering plans to create a new research park financed in part by the powerful Wallenberg family.
Anglo-Swedish pharmaceuticals giant AstraZeneca on Thursday said its net profits sank 56 percent in the third quarter, as group revenues tumbled on the expiry of key drug patents.
Anglo-Swedish pharmaceuticals giant AstraZeneca is closing its research facilities in Södertälje, south of Stockholm, as part of a major restructuring, resulting in the loss of around 1,000 Swedish jobs.
Anglo-Swedish pharmaceuticals firm AstraZeneca announced on Thursday that the US Food and Drug Administration (FDA) has approved its Brilinta heart drug for use on patients in the United States.
